Loperamide Dosage for Managing Excessive Ostomy Output

Initial Dosing Recommendations

For ostomy patients, 1-2 tablets (2-4 mg) of loperamide taken 30 minutes before meals is recommended as standard practice, with the goal of reducing intestinal output after eating, especially in patients who are net "secretors" 1, 4
The European Society of Coloproctology recommends administering loperamide before meals as timing is crucial, with intestinal output rising after eating 2, 3, 5

For patients with disrupted enterohepatic circulation, higher doses of loperamide (12-24 mg at a time) may be required, with the American Gastroenterological Association suggesting that these patients may need more frequent dosing 2, 3, 5

The British Society of Gastroenterology recommends that if tablets emerge unchanged in stomal output, they can be crushed, opened, mixed with water, or put on food to improve absorption, and notes that loperamide is preferred over codeine phosphate as it is not sedative, addictive, and does not cause fat malabsorption 2, 3, 5
For patients with very short bowel or rapid transit, the European Society of Coloproctology suggests that more frequent dosing may be necessary 2

The American Gastroenterological Association recommends monitoring effectiveness by measuring stoma output volume, with an expected reduction of approximately 20-30% in water and sodium output from an ileostomy, and suggests combining loperamide with dietary modifications to optimize management 2, 3
The European Society of Coloproctology recommends combining loperamide with dietary modifications, including thickening foods, and adding oral rehydration solution containing appropriate sodium concentration (90-100 mmol/L) for patients with output exceeding 1 liter per day 1, 4, 6

The American College of Gastroenterology recommends considering adding antisecretory drugs, such as proton pump inhibitors, and codeine phosphate may have synergistic effects when combined with loperamide in difficult cases, with the American Gastroenterological Association noting that octreotide may be beneficial for very high-output stomas 2, 3, 7

The Clinical Gastroenterology and Hepatology society notes that medication reviews by clinical pharmacists are important for ostomy patients, and recommends avoiding sustained- or delayed-release medications in patients with short bowel syndrome, as absorption may be compromised 7